Small cell carcinoma presenting as an extrapulmonary neoplasm

sites of origin and response to chemotherapy

R. M. Levenson, D. C. Ihde, M. J. Matthews, M. H. Cohen, A. F. Gazdar, P. A. Bunn, J. D. Minna

Research output: Contribution to journalArticle

151 Citations (Scopus)

Abstract

Eight (4%) of 203 consecutive prospectively staged and treated patients with small cell carcinoma (SCC) had no evidence of pulmonary or mediastinal tumor on chest roentgenogram or at fiberoptic bronchoscopy at the time of diagnosis. There were two distinct clinical presentations in these SCC patients with exclusively extrapulmonary tumors. Four had discrete localized extrapulmonary neoplasms, presumably originating in these sites. In the other 4 cases with either regional or widely metastatic disease, no obvious primary tumor could be documented in the lungs or elsewhere. One complete and two partial responses to chemotherapy (duration 6 to > 11 mo) occurred in 6 evaluable patients. Two remaining patients were inevaluable for response because they received adjuvant chemotherapy after irradiation or excision of the primary tumor and are free of disease at 15 and 28 months. Results document two clinicopathologic entities of extrapulmonary SCC, more firmly establish that it can be responsive to chemotherapy, and encourage systemic therapy as part of initial treatment planning.

Original languageEnglish (US)
Pages (from-to)607-612
Number of pages6
JournalJournal of the National Cancer Institute
Volume67
Issue number3
StatePublished - 1981

Fingerprint

Neoplasms by Site
Small Cell Carcinoma
Drug Therapy
Neoplasms
Lung
Bronchoscopy
Adjuvant Chemotherapy
Thorax
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Small cell carcinoma presenting as an extrapulmonary neoplasm : sites of origin and response to chemotherapy. / Levenson, R. M.; Ihde, D. C.; Matthews, M. J.; Cohen, M. H.; Gazdar, A. F.; Bunn, P. A.; Minna, J. D.

In: Journal of the National Cancer Institute, Vol. 67, No. 3, 1981, p. 607-612.

Research output: Contribution to journalArticle

Levenson, R. M. ; Ihde, D. C. ; Matthews, M. J. ; Cohen, M. H. ; Gazdar, A. F. ; Bunn, P. A. ; Minna, J. D. / Small cell carcinoma presenting as an extrapulmonary neoplasm : sites of origin and response to chemotherapy. In: Journal of the National Cancer Institute. 1981 ; Vol. 67, No. 3. pp. 607-612.
@article{72dd8b59686140c984d867cf83d420cd,
title = "Small cell carcinoma presenting as an extrapulmonary neoplasm: sites of origin and response to chemotherapy",
abstract = "Eight (4{\%}) of 203 consecutive prospectively staged and treated patients with small cell carcinoma (SCC) had no evidence of pulmonary or mediastinal tumor on chest roentgenogram or at fiberoptic bronchoscopy at the time of diagnosis. There were two distinct clinical presentations in these SCC patients with exclusively extrapulmonary tumors. Four had discrete localized extrapulmonary neoplasms, presumably originating in these sites. In the other 4 cases with either regional or widely metastatic disease, no obvious primary tumor could be documented in the lungs or elsewhere. One complete and two partial responses to chemotherapy (duration 6 to > 11 mo) occurred in 6 evaluable patients. Two remaining patients were inevaluable for response because they received adjuvant chemotherapy after irradiation or excision of the primary tumor and are free of disease at 15 and 28 months. Results document two clinicopathologic entities of extrapulmonary SCC, more firmly establish that it can be responsive to chemotherapy, and encourage systemic therapy as part of initial treatment planning.",
author = "Levenson, {R. M.} and Ihde, {D. C.} and Matthews, {M. J.} and Cohen, {M. H.} and Gazdar, {A. F.} and Bunn, {P. A.} and Minna, {J. D.}",
year = "1981",
language = "English (US)",
volume = "67",
pages = "607--612",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Small cell carcinoma presenting as an extrapulmonary neoplasm

T2 - sites of origin and response to chemotherapy

AU - Levenson, R. M.

AU - Ihde, D. C.

AU - Matthews, M. J.

AU - Cohen, M. H.

AU - Gazdar, A. F.

AU - Bunn, P. A.

AU - Minna, J. D.

PY - 1981

Y1 - 1981

N2 - Eight (4%) of 203 consecutive prospectively staged and treated patients with small cell carcinoma (SCC) had no evidence of pulmonary or mediastinal tumor on chest roentgenogram or at fiberoptic bronchoscopy at the time of diagnosis. There were two distinct clinical presentations in these SCC patients with exclusively extrapulmonary tumors. Four had discrete localized extrapulmonary neoplasms, presumably originating in these sites. In the other 4 cases with either regional or widely metastatic disease, no obvious primary tumor could be documented in the lungs or elsewhere. One complete and two partial responses to chemotherapy (duration 6 to > 11 mo) occurred in 6 evaluable patients. Two remaining patients were inevaluable for response because they received adjuvant chemotherapy after irradiation or excision of the primary tumor and are free of disease at 15 and 28 months. Results document two clinicopathologic entities of extrapulmonary SCC, more firmly establish that it can be responsive to chemotherapy, and encourage systemic therapy as part of initial treatment planning.

AB - Eight (4%) of 203 consecutive prospectively staged and treated patients with small cell carcinoma (SCC) had no evidence of pulmonary or mediastinal tumor on chest roentgenogram or at fiberoptic bronchoscopy at the time of diagnosis. There were two distinct clinical presentations in these SCC patients with exclusively extrapulmonary tumors. Four had discrete localized extrapulmonary neoplasms, presumably originating in these sites. In the other 4 cases with either regional or widely metastatic disease, no obvious primary tumor could be documented in the lungs or elsewhere. One complete and two partial responses to chemotherapy (duration 6 to > 11 mo) occurred in 6 evaluable patients. Two remaining patients were inevaluable for response because they received adjuvant chemotherapy after irradiation or excision of the primary tumor and are free of disease at 15 and 28 months. Results document two clinicopathologic entities of extrapulmonary SCC, more firmly establish that it can be responsive to chemotherapy, and encourage systemic therapy as part of initial treatment planning.

UR - http://www.scopus.com/inward/record.url?scp=0019442167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019442167&partnerID=8YFLogxK

M3 - Article

VL - 67

SP - 607

EP - 612

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 3

ER -